Whitnell & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Whitnell & Co’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,138	Closed	-$35K	–	256
2019 Q1	$35K	Buy	+1,138	New	+$38.1K	0.01%	195

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitnell & Co's ASXC Position: Q2 2019 in Review

Whitnell & Co sold out of Asensus Surgical, Inc. (ASXC) in Q2 2019, closing a stake of 1,138 shares — an estimated $35K sold.

Whitnell & Co first reported a position in ASXC in Q1 2019 and held it in 1 quarter. The position peaked at $35K in Q1 2019. 141 funds tracked by Wall St. Rank hold ASXC as of Q2 2019.

Whitnell & Co reported no remaining Asensus Surgical, Inc. position as of Q2 2019 after selling out during the quarter.
Whitnell & Co sold 1,138 Asensus Surgical, Inc. shares in Q2 2019, an estimated $35K.
Whitnell & Co first reported a position in Asensus Surgical, Inc. in Q1 2019 and held it in 1 quarter.
Whitnell & Co's Asensus Surgical, Inc. position peaked at $35K in Q1 2019.
141 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2019.

Based on Whitnell & Co's 13F filing for Q2 2019, filed 16 Jul 2019.